Liang Lu
Chairman at Shanghai MicuRx Pharmaceutical Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zhi Le Li | M | 46 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
 Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 6 years |
| Zheng Yu Yuan | M | 69 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 12 years |
| Hong Yuan | F | 47 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 4 years |
| Wei Cheng Zhou | M | 66 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 1 years |
| Yan Gui Chen | M | 42 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | - |
| Han Mei Huang | F | 43 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 4 years |
| Yee Kwan Law | M | 71 |
The Hong Kong University of Science & Technology
| 12 years |
| Yan Jin | F | 46 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 4 years |
| Jian Duan | M | 64 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 4 years |
| Xing Hai Wang | M | 43 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 14 years |
| Dong Mei Ji | F | 50 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | - |
| Dong Ming Zhao | M | 54 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 4 years |
| Sheng Lu | M | - |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dai Jie Chen | M | 67 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | 3 years |
| Qun Bao | M | 46 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | - |
| Chang Liu | F | 35 |
The Hong Kong University of Science & Technology
| 5 years |
| Kit Shun Yeung | F | 49 |
The Hong Kong University of Science & Technology
| 2 years |
| Melissa Chen | F | - |
The Hong Kong University of Science & Technology
| 3 years |
| Kam Yin Yan | F | 44 |
The Hong Kong University of Science & Technology
| 2 years |
| Tsz Kei Lee | F | 31 |
The Hong Kong University of Science & Technology
| 4 years |
| Daniel Yao | M | - |
The Hong Kong University of Science & Technology
| 4 years |
| Yue Ming Hu | M | 53 |
The Hong Kong University of Science & Technology
| 1 years |
| Chi Yin Ng | M | 38 |
The Hong Kong University of Science & Technology
| 2 years |
| Jing Z. Wang | F | - |
The Hong Kong University of Science & Technology
| 2 years |
| Wan Yee Chui | M | 45 |
The Hong Kong University of Science & Technology
| 2 years |
| Dong Ma | M | 41 |
Shanghai Institute of Pharmaceutical Industry
| 1 years |
| Chen Jun | M | 42 |
The Hong Kong University of Science & Technology
| 2 years |
| Xing Shun Luo | M | 49 |
The Hong Kong University of Science & Technology
| 2 years |
| Boyang Zhu | M | 38 |
The Hong Kong University of Science & Technology
| 1 years |
| Minqi Shan | M | - |
The Hong Kong University of Science & Technology
| 2 years |
| Zhi Ming Ma | M | 42 |
The Hong Kong University of Science & Technology
| 3 years |
| Zach Wiersma | M | - |
The Hong Kong University of Science & Technology
| - |
| Alip | M | 48 |
The Hong Kong University of Science & Technology
| 2 years |
| Stefano de Vivo | M | 46 |
The Hong Kong University of Science & Technology
| 3 years |
| Hans Jebsen | M | 67 |
The Hong Kong University of Science & Technology
| 2 years |
| Yu Cheng | M | 47 |
The Hong Kong University of Science & Technology
| 2 years |
| Ka Cheong Leung | M | 33 |
The Hong Kong University of Science & Technology
| 4 years |
| Alex Guyer | M | - |
The Hong Kong University of Science & Technology
| 1 years |
| Feng Han | M | 42 |
The Hong Kong University of Science & Technology
| 2 years |
| Jim Wai Hang | M | - |
The Hong Kong University of Science & Technology
| 4 years |
| Selina Li | F | - |
The Hong Kong University of Science & Technology
| 4 years |
| Rufo de la Rosa | M | - |
The Hong Kong University of Science & Technology
| 2 years |
| Qinglei Zuo | M | 40 |
Shanghai Institute of Pharmaceutical Industry
| 1 years |
| Bao Hua Chen | F | 46 |
The Hong Kong University of Science & Technology
| 2 years |
| Wei Guo Xu | M | 50 |
The Hong Kong University of Science & Technology
| 2 years |
| Pin Zhu | M | - |
The Hong Kong University of Science & Technology
| 1 years |
| Ying Luo | F | 53 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | - |
| Wei Cong Ni | F | - |
The Hong Kong University of Science & Technology
| 4 years |
| Violet Ho | F | - |
The Hong Kong University of Science & Technology
| 4 years |
| Jing Li | F | 32 |
The Hong Kong University of Science & Technology
| 1 years |
| Pei Hua Li | F | - |
The Hong Kong University of Science & Technology
| 1 years |
| Qi Hui Peng | F | 31 |
The Hong Kong University of Science & Technology
| 1 years |
| Jan Engels | M | - |
The Hong Kong University of Science & Technology
| 3 years |
| Su Yu Li | F | 35 |
The Hong Kong University of Science & Technology
| 1 years |
| Stan Lewis | M | - |
The Hong Kong University of Science & Technology
| 2 years |
| Clarence Yunze Deng | M | - |
The Hong Kong University of Science & Technology
| 4 years |
| Cong Yan Xue | M | 49 |
The Hong Kong University of Science & Technology
| 1 years |
| Yumeng Wang | F | 33 |
The Hong Kong University of Science & Technology
| 4 years |
| Yin Shun Wong | M | 43 |
The Hong Kong University of Science & Technology
| 1 years |
| Fei Gao | M | 44 |
The Hong Kong University of Science & Technology
| 2 years |
| Lu Jiang Liao | M | 52 |
The Hong Kong University of Science & Technology
| 2 years |
| Nicky Linck | F | - |
The Hong Kong University of Science & Technology
| 2 years |
| Chun Bong So | M | 38 |
The Hong Kong University of Science & Technology
| 2 years |
| Shu Fen Deng | F | 60 |
The Hong Kong University of Science & Technology
| 2 years |
| Chun Fai Lee | M | 53 |
The Hong Kong University of Science & Technology
| 2 years |
| Jian Guo | M | 60 |
The Hong Kong University of Science & Technology
| 2 years |
| Ning Zhong | M | 41 |
The Hong Kong University of Science & Technology
| 2 years |
| Yu Ze Han | M | 60 |
The Hong Kong University of Science & Technology
| 2 years |
| Shaun Clark | M | - |
The Hong Kong University of Science & Technology
| 1 years |
| Wai Shing Chan | M | 44 |
The Hong Kong University of Science & Technology
| 1 years |
| Yi Hong Zhao | M | 58 |
The Hong Kong University of Science & Technology
| 2 years |
| Wilson Agung Pranoto | M | 42 |
The Hong Kong University of Science & Technology
| 2 years |
| Alexander Agung Pranoto | M | 70 |
The Hong Kong University of Science & Technology
| 2 years |
| Bin Hua Luo | M | 59 |
The Hong Kong University of Science & Technology
| 2 years |
| Yat Bond Pang | M | 48 |
The Hong Kong University of Science & Technology
| 3 years |
| Pei Kun Huang | M | 61 |
The Hong Kong University of Science & Technology
| 2 years |
| Li Min Guo | M | 61 |
The Hong Kong University of Science & Technology
| 2 years |
| Yi Jin Li | F | 53 |
The Hong Kong University of Science & Technology
| 2 years |
| Guo Ping Li | M | 47 |
The Hong Kong University of Science & Technology
| 2 years |
| Satoshi Tominaga | M | 46 |
The Hong Kong University of Science & Technology
| 1 years |
| King Yan Chiu | M | 46 |
The Hong Kong University of Science & Technology
| 1 years |
| Ting Luo | M | 44 |
The Hong Kong University of Science & Technology
| 2 years |
| Yun Li Zou | F | 51 |
The Hong Kong University of Science & Technology
| 2 years |
| Hau Zen Hwang | M | 52 |
The Hong Kong University of Science & Technology
| 1 years |
| Wang Xia Zhang | F | 47 |
The Hong Kong University of Science & Technology
| 2 years |
| Chee Chung Wong | M | 47 |
The Hong Kong University of Science & Technology
| 1 years |
| Huan Qing Wang | M | 52 |
The Hong Kong University of Science & Technology
| 2 years |
| Ching Sum Chan | M | 42 |
The Hong Kong University of Science & Technology
| 1 years |
| King Wai Wong | M | 41 |
The Hong Kong University of Science & Technology
| 2 years |
| Sze Lai Chan | M | 44 |
The Hong Kong University of Science & Technology
| 1 years |
| Leong Li | M | 40 |
The Hong Kong University of Science & Technology
| 1 years |
| Hua Dong | M | 57 |
The Hong Kong University of Science & Technology
| 2 years |
| Xiao Dong Jia | M | 36 |
The Hong Kong University of Science & Technology
| 1 years |
| Mick Aguirre | M | - |
The Hong Kong University of Science & Technology
| 2 years |
| Ronghao Yu | M | - |
The Hong Kong University of Science & Technology
| 4 years |
| Shu Pai Li | M | 47 |
The Hong Kong University of Science & Technology
| 2 years |
| Lai Sheung Pang | M | 57 |
The Hong Kong University of Science & Technology
| 2 years |
| Kin Shan Yuen | M | 42 |
The Hong Kong University of Science & Technology
| 2 years |
| Guang Su | M | 45 |
The Hong Kong University of Science & Technology
| 1 years |
| Yun Xian Qian | M | 35 |
The Hong Kong University of Science & Technology
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Hong Kong | 83 | 83.00% |
| China | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Liang Lu
- Personal Network
